In fact, hormone-refractory prostate cancer cells often can maintain functional AR signaling despite greatly reduced levels of circulating testosterone as, for instance, with orchiectomy (Deutsch et al. 2004) because of AR overexpression. This evidence concerns the gene AR and prostate cancer.